RDI is your full-service, integrated partner for IVD research
We bring together a high-complexity CLIA lab, a technology-enabled CRO, and a clinical and laboratory site network to accelerate your product’s development.
Our Mission
Unlike many other CROs, RDI can source, test, and submit to the FDA, simplifying the clinical trial process while serving as a credible, unbiased, and independent source for the FDA submission.
RDI is the leader in diagnostic trials. Let us be your first call to accelerate your IVD product to market.
Our Story
2008
RDI Founded by Scientist
RDI was founded by an ex-Siemens assay validation scientist, foreseeing a need for an interdependent IVD specialist that could accelerate trials with a physician and lab network trained in research.
2017
RDI Brings in Expert Leadership
RDI was acquired by an investor group led by Conall Arora to further professionalize operations and expand its physician network through a custom developed and paperless trial management system.
2022
RDI Invests in Physician Network
RDI hires a dedicated site network team, armed with insurance claims data to better target any physician in the country.
2023
RDI Adds CLIA Lab and Upgrades Scientific Leadership
RDI received CLIA certification after hiring Dr. Michael Samoszuk as its new principal investigator and medical lab director and Dr. Elisa Romeo to serve as lead principal investigator for prospective collections.
2024
RDI continues to be at the forefront of services and safety with accreditation through the College of American Pathologists (CAP).
Our Team
A Partnership-Focused Approach
We have fostered strong relationships with our partners, including lab suppliers and IRBs. By taking a collaborative approach, we also build long-lasting and productive partnerships with our clients, many of which are top 5-10 IVD companies.
Upcoming Events
Stay tuned for upcoming events!